A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
about
Updates in the understanding and treatments of skin & hair disorders in women of colorA randomized, split-face clinical trial of Q-switched alexandrite laser versus Q-switched Nd:YAG laser in the treatment of bilateral nevus of Ota.Efficacy of 694-nm fractional Q-switched ruby laser (QSRL) combined with sonophoresis on levorotatory vitamin C for treatment of melasma in Chinese patients.A pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's Melanosis.Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?Comparative study of dual-pulsed 1064 nm Q-switched Nd:YAG laser and single-pulsed 1064 nm Q-switched Nd:YAG laser by using zebrafish model and prospective split-face analysis of facial melasma.Pulsed alexandrite laser for treatment of melasma in Asian patients.Commentary for: Facial rejuvenation via the sequential combined use of multiple laser modalities: Safety and efficacy.Lasers in Melasma: A Review with Consensus Recommendations by Indian Pigmentary Expert Group.Evidence-based Review, Grade of Recommendation, and Suggested Treatment Recommendations for Melasma.Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.Updates in the understanding and treatments of skin & hair disorders in women of color.
P2860
Q33640681-ED0B832F-7216-499A-9F93-D72524D4C352Q35629135-DA917A7A-38FC-4496-98BD-718D51CC0C8EQ36002500-2FCFEFC1-FCFE-427A-9054-5BE1F91451AEQ36062018-DC1388FD-FB1D-47A0-B8D0-D091CDAFA69BQ36062741-24B536EB-754A-49D9-BD26-50FD893428ADQ36211638-C9C0E216-B44B-43A9-ABDA-621D87C6EB5EQ36267177-9CF87135-8CA6-41D2-8305-4185BD0E2928Q46154307-0B5AE472-E778-436A-B437-4B489BC95E74Q47137820-E8E0D462-FEFC-4E88-A3D5-058F574F7556Q47158180-542C44E0-239B-4F1B-87D4-4B1F6F969F42Q48346885-155D034D-E4E6-4A21-9CA3-30EDAAC8AF98Q50062971-47D89AC8-C779-4E86-BE54-1FFFFE726E7DQ53606173-B3A034D5-5912-4B8C-82DE-7DC84A12635A
P2860
A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A randomized, split-face clini ...... e treatment of facial melasma.
@ast
A randomized, split-face clini ...... e treatment of facial melasma.
@en
type
label
A randomized, split-face clini ...... e treatment of facial melasma.
@ast
A randomized, split-face clini ...... e treatment of facial melasma.
@en
prefLabel
A randomized, split-face clini ...... e treatment of facial melasma.
@ast
A randomized, split-face clini ...... e treatment of facial melasma.
@en
P2093
P2860
P356
P1476
A randomized, split-face clini ...... e treatment of facial melasma.
@en
P2093
Ane B Niwa Massaki
Daniel P Friedmann
Mitchel P Goldman
Sabrina G Fabi
P2860
P304
P356
10.1002/LSM.22263
P577
2014-06-04T00:00:00Z